l o a d i n g
:::

網路掛號

字級:

:::
首頁 > 團隊介紹 > 范綱行 醫生資料

范綱行

醫師

頭頸部腫瘤、鼻咽癌、攝護腺癌、泌尿道腫瘤

醫生資料

現職

  • 新北市立土城醫院放射腫瘤科助理教授級主治醫師

經歷

  • 2005 ~ 迄 今 林口長庚醫院放射腫瘤科主治醫師
  • 2004 ~ 2005 林口長庚醫院放射腫瘤科總醫師
  • 2001 ~ 2004 林口長庚醫院放射腫瘤科住院醫師
  • 2000 ~ 2001 林口長庚醫院實習醫師

學歷

  • 2006 ~ 迄 今 長庚大學臨床醫學研究所博士班
  • 2001 畢業於 台北醫學大學醫學系

語言

  • 國語,英語,閩南語

教職

  • 助理教授

學會與認證

  • 台灣放射腫瘤學會
  • 美國放射腫瘤學會
  • 臺灣頭頸部腫瘤醫學會

論文及期刊發表

  • Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival.
  • Adjuvant and salvage radiotherapy for urothelial cell carcinoma of the upper urinary tract: experience in a single institution.
  • GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients receiving radiotherapy.
  • Outcome analysis of patients with well-differentiated oral cavity squamous cell carcinoma.
  • The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity.
  • Identification of a high-risk subgroup of patients with resected pT3 oral cavity cancer in need of postoperative adjuvant therapy.
  • PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma.
  • PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity.
  • Tongue and buccal mucosa carcinoma: is there a difference in outcome?
  • Primary Tumor Site as a Predictor of Treatment Outcome for Definitive Radiotherapy of Advanced-Stage Oral Cavity Cancers.
  • Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy.
  • Treatment rults of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates.
  • Outcome Analysis of Patients with pN2 Oral Cavity Cancer.
  • Hypothyroidism After Radiotherapy for Nasopharyngeal Cancer Patients.
  • Prognostic significance of immunohistochemically detected lymph node micrometastases in pT0N0 esophageal squamous cell carcinoma.
  • Adjuvant androgen deprivation lost its benefit after premature termination: an experience of combined modality treatment on prostate cancer.
  • To customize radiotherapy record sheet with ARIA oncology information system.
  • Using Sybase InfoMaker To design and output clinical reports From ARIA Oncology Information System.
  • Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy. .
  • Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up.
  • Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: The role of standardized uptake value.
  • Treatment outcome of combined modalities for buccal cancers: unilateral or bilateral neck radiation?
  • Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection.
  • High-Dose-Rate Brachytherapy Plus External Beam Radiotherapy for T1 to T3 Prostate Cancer: An Experience in Taiwan.
  • Combined Modality Treatment for Advanced Oral Tongue Squamous Cell Carcinoma.
  • Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
  • 18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma.
  • Preliminary Treatment Results of Intensity-Modulated Radiotherapy for Prostate Cancer.
  • Treatment results of tongue cancer in patient younger than 40 years old.
  • The effect of fixed couch-isocenter distance treatment on radiotherapy in rectal cancer patients.